Pharmacogenetic Dosing Recommendations Sorely Needed By Clinicians, Formularies, SACGHS Says
This article was originally published in The Pink Sheet Daily
Tests are currently available to identify patient responders, but clinicians need guidance on how to adjust dosing for them, the HHS Secretary's Advisory Committee on Genetics, Health & Society agreed.
You may also be interested in...
The Solicitor General says the Supreme Court should not hear the Commission's appeal of a case brought against Schering-Plough regarding a generic drug settlement.
Fox Chase Cancer Center’s Weeks concurs that umbrella agreements with pharma and biotech companies are becoming more common.
One example of the value of genotyping is Genentech's Herceptin, committee members agreed.